MRVI Maravai LifeSciences
Maravai LifeSciences earnings company data as of 4:46 AM ET 10/24
Limited consensus data for this ticker (thin coverage or data-plan limits).
Dates may be company-announced rather than sell-side consensus.
Calendar and recent prints remain the primary lens when available.
Scheduled
1 period, newest first, nothing reported yet. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 4 Nov | EPS | — | — | — |
| Rev | — | — | — |
Insider trades
Open-market buys and sales by MRVI's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $1.9M bought by 2 insiders
- None no sales outside a trading plan
- $254K sold by 1 insider under 10b5-1 plans
-
Kurt Oreshack General CounselPlanned sale$254K 50,000 shares at $5.08 13% of stakeTraded Jun 9–10 Filed Jun 10
-
Gregory T Lucier DirectorBuy$369K 100,000 shares at $3.69 +181% to stakeTraded Dec 5–8 Filed Dec 9, 2025
-
Bernd Brust CEOBuy$703K 216,212 shares at $3.25 +86% to stakeTraded Nov 13, 2025 Filed Nov 17, 2025
-
Bernd Brust CEOBuy$809K 250,559 shares at $3.23 New stakeTraded Nov 11–12 Filed Nov 13, 2025
Also filed in the last 12 months, not counted as buying or selling: 13 share withholdings for taxes, 10 stock grants, and 2 gifts.
SEC filings
Recent issuer filings from EDGAR, 17 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 1.01,1.02,2.03,7.01,9.01 | Filing Doc | |
| 8-K | 5.07 | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc | |
| DEFA14A | Filing Doc | ||
| DEF 14A | Filing Doc | ||
| 10-K | Filing Doc | ||
| 8-K | 2.02,9.01 | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.